Previous Article | Next Article ![]()
Journal of Bacteriology, September 2000, p. 4773-4782, Vol. 182, No. 17
Institut für Organische Chemie, Universität
Innsbruck, A-6020 Innsbruck, Austria,1 and
Institut für Angewandte Mikrobiologie, Universität
Ulm, D-89069 Ulm,2 and Laboratorium
für Mikrobiologie, Fachbereich Biologie,
Phillips-Universität Marburg, D-35032
Marburg,3 Germany
Received 15 March 1999/Accepted 6 June 2000
The corrinoids from the obligate anaerobe Clostridium
cochlearium were extracted as a mixture of
Co Besides vitamin B12
(cyanocobalamin) itself, a spectrum of corrinoids is provided in nature
which differ from vitamin B12 by their cobalt-coordinating
axial ligands (29). While the corrin moiety of the naturally
occurring corrinoids is completely conserved structurally, a
rationalized feature of (the catalytic moieties of) essential cofactors
(24), the "complete" B12 derivatives contain
a remarkable variety of aromatic nucleotide functions: benzimidazoles
(such as 5-methylbenzimidazole, 5,6-dimethylbenzimidazole [DMB],
5-hydroxybenzimidazole, and 5-methoxybenzimidazole), purine bases (such
as adenine or 2-methyladenine) (see Fig. 1) or phenols (phenol and
p-cresol) (29, 43, 61, 67). In contrast to the situation in the other widespread adenine-containing dinucleotide cofactors, in pseudovitamin B12
(Co
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Native Corrinoids from Clostridium cochlearium Are
Adeninylcobamides: Spectroscopic Analysis and Identification of
Pseudovitamin B12 and Factor A
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-cyano derivatives. From 50 g of frozen cells,
approximately 2 mg (1.5 µmol) of B12 derivatives was
obtained as a crystalline sample. Analysis of the corrinoid sample of
C. cochlearium by a combination of high-pressure liquid
chromatography and UV-Vis absorbance spectroscopy revealed the presence
of three cyano corrinoids in a ratio of about 3:1:1. The spectroscopic
data acquired for the sample indicated the main components to be
pseudovitamin B12
(Co
-cyano-7"-adeninylcobamide) (60%) and factor A
(Co
-cyano-7"-[2-methyl]adeninylcobamide) (20%).
Authentic pseudovitamin B12 was prepared by guided
biosynthesis from cobinamide and adenine. Both pseudovitamin
B12 and its homologue, factor A, were subjected to complete
spectroscopic analysis by UV-Vis, circular dichroism, mass
spectrometry, and by one- and two-dimensional 1H,
13C-, and 15N nuclear magnetic resonance (NMR)
spectroscopy. The third component was indicated by the mass spectra to
be an isomer of factor A and is likely (according to NMR) to be
7"-[N6-methyl]-adeninylcobamide, a previously
unknown corrinoid. C. cochlearium thus biosynthesizes as
its native "complete" B12 cofactors the
7"-adeninylcobamides and two homologous corrinoids, in which the
nucleotide base is a methylated adenine.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-cyano-7"-adeninylcobamide) and in factor A
(Co
-cyano-7"-[2-methyl]adeninylcobamide; Fig.
1), the ribose function is part of an
unusual
-nucleotide moiety and binds to N7 of the purine ring. This
latter property has been suggested by D. C. Hodgkin to be required
in adeninylcobamides in order to enable the purine base to coordinate
intramolecularly to the corrin-bound cobalt center via its N9 (30,
31, 41).

View larger version (24K):
[in a new window]
FIG. 1.
Structural formulae of vitamin B12
derivatives. The general formulae are given on the left; variation of
the organic ligand R (Me, methyl; Ado, 5'-deoxy-5'-adenosyl) and/or of
the nucleotide base give rise to the different cobamides. (Top) Base-on
cobamides vitamin B12 (cyanocobalamin), methylcobalamin,
coenzyme B12 (5'-deoxy-5'-adenosylcobalamin), pseudovitamin
B12 (Co
-cyano-7"-adeninylcobamide),
Co
-methyl-7"-adeninylcobamide, factor A
(Co
-cyano-7"-[2-methyl]adeninylcobamide),
Co
-methyl-7"-[2-methyl]adeninylcobamide, and
Co
-cyano-7"-[N6-methyl]adeninylcobamide.
(Bottom) Base-off cobamides pseudocoenzyme B12
(5'-deoxy-5'-adenosyl-7"-adeninylcobamide) and adenosyl factor A
(5'-deoxy-5'-adenosyl-7"-[2-methyl]-adeninylcobamide).
Three years after the discovery of vitamin B12 (62,
64), pseudovitamin B12 was isolated from an
incompletely identified microorganism that was obtained from rumen
contents (20). In 1958 the coenzyme form of pseudovitamin
B12 (i.e., pseudocoenzyme B12) was discovered
and identified by UV and visible (UV-Vis) spectroscopy to be the native
cofactor of Clostridium tetanomorphum (2). Factor
A was the main component of a mixture of corrinoids which were isolated
in a crystalline form from pig manure, bovine gut contents, and feces
(25, 26, 29). Pseudovitamin B12 and factor A
often occur in anaerobically fermenting systems, such as ruminal
(7) and intestinal (12) contents, feces, and
sewage sludge (29). The crystal structure of factor A was determined in 1981 and confirmed the presence of an
-nucleotide and
binding of N9 of the purine ring to the corrin-bound cobalt center
(41). The different nucleotide bases in factor A and in
vitamin B12 lead only to small differences in the axial
bond lengths, in bond angles, and in the gross three-dimensional (3D) structures of vitamin B12 and factor A. The axial bond
lengths of factor A [(Co---C) bond length = 1.86 Å and (Co---N)
bond length = 2.12 Å] (41) differ only marginally
from those of vitamin B12 [(Co---C) bond length = 1.86 Å and (Co---N) bond length = 2.01 Å] (45). The
longer (Co---N) bond in factor A clearly is the consequence of a weaker
coordinating adenine heterocycle compared to the more nucleophilic DMB
base of vitamin B12.
Pseudovitamin B12 and factor A have been found specifically in a variety of microorganisms, e.g., in Clostridium (2, 28), Propionibacterium (29), and methanogenic (pseudovitamin B12) bacteria (66). Remarkably, Salmonella enterica serovar Typhimurium synthesizes cobalamins under microaerophilic conditions, while pseudovitamin B12 and factor A are found in serovar Typhimurium, when grown strictly anaerobically (39). Whereas aerobic microorganisms have developed a particularly efficient way to biosynthesize the DMB base of their cobalamins from flavine, the biosynthetic access to DMB is now known to be a complex task in obligate anaerobes (60).
Guided biosynthesis opens access to natural but commercially unavailable complete corrinoids and often is also applicable to the synthesis of complete cobamides, whose nucleotide base differs from the known ones, by supplementing the bacterial culture with a suitable nucleotide base precursor (see, for example, reference 29). Early on, the preparation by "guided biosynthesis" of pseudovitamin B12 and factor A was explored, e.g., by means of Escherichia coli, by adding both cobinamide and adenine or 2-methyladenine to the growth medium (27). A range of related fermentation methods for the production of these purinylcobamides were developed, based on other microorganisms, most notably Propionibacterium spp. (13). In line with this, guided biosynthesis has also been employed for the preparation of nonnatural cobamides, such as naphthimidazolyl- and imidazolylcobamides (22, 45, 59, 65), using cultures of Propionibacterium freudenreichii and P. shermanii.
The nature and the role of the nucleotide base in complete corrinoids has attained renewed interest lately (43): electron spin resonance (ESR) spectroscopic work by Stupperich et al. revealed the coordination of histidine to the protein-bound phenolyl-cobamides in the homoacetogenic Sporomusa ovata (67). On the other hand, the bound corrinoid in the corrinoid-iron-sulfur protein involved in the synthesis of acetyl-coenzyme A from Clostridium thermoaceticum was indicated by spectroscopic means to be "base-off," i.e., to have the nucleotide base of the corrinoid decoordinated in the protein (57). A pioneering structure analysis by Drennan et al. of the B12-binding domain of a methionine synthase from E. coli that depends upon methylcobalamin as a cofactor (21, 51) uncovered the "base-off-His-on" form of the protein-bound complete methylcorrinoid, in which a proteinic histidine residue displaces the cobalt-coordinating DMB base of the corrinoid cofactor. The relevance of the base-off-His-on mode of binding of corrinoids in cobamide-dependent enzymes (46, 72) was supported further by two additional crystal structures, of methylmalonyl coenzyme A mutase (52) and glutamate mutase (58), which both depend upon an adenosylcobamide as a cofactor, such as coenzyme B12 (5'-deoxy-5'-adenosylcobalamin). In contrast, the crystal structure of a diol dehydratase showed the bound coenzyme B12 in its "classic" base-on constitution (63). Accordingly, questions concerning the effect of the nucleotide base on the binding the B12 cofactors by their apoproteins (35, 53, 69) and on the mechanisms of B12-dependent enzymatic reactions have received more attention (15, 43).
Ongoing studies in our laboratories concern adenosylcobamide-dependent glutamate mutase from C. cochlearium (9, 35), as well as from C. tetanomorphum (55, 69), which catalyzes the conversion of L-glutamate to (2S,3S)-3-methyl aspartate, a particularly intriguing mechanistic puzzle (9, 15). In connection with this work, the crystal structure of inactive recombinant glutamate mutase from C. cochlearium, reconstituted with vitamin B12 and methylcobalamin, was determined recently (58). Experiments concerning B12 binding and enzyme catalysis (6, 10, 17, 37, 54, 72) have been carried out with coenzyme B12, although pseudocoenzyme B12 is known to be the natural cofactor in C. tetanomorphum (2). The identity of the native cofactor(s) of the related C. cochlearium was therefore of interest.
We report here the identification of two of the three native corrinoids of C. cochlearium in their stable cyano-Co(III) form by means of a comparison of their UV-Vis, circular dichroism (CD), mass, and nuclear-magnetic-resonance (NMR) spectra with the spectra of authentic samples of pseudovitamin B12 and factor A. Authentic samples of pseudovitamin B12, prepared by guided biosynthesis using Propionibacterium acidi-propionici, and of factor A, were both subjected to detailed spectroscopic analysis. In particular, complete NMR signal assignment of both pseudovitamin B12 and factor A was carried out to achieve the first thorough spectroscopic analysis of purine analogues of vitamin B12. A third corrinoid compound was found, which was tentatively assigned the structure of the novel 7"-[N6-methyl]adeninylcobamide. In this way, the corrinoid sample from C. cochlearium was shown to contain three cobamides, pseudovitamin B12, factor A, and an unknown isomer of factor A, in a ratio of ca. 3:1:1.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Strains and sources of organisms. The strains used were P. acidi-propionici DSM 20273 and C. cochlearium DSM 1285.
Reagents and solvents.
Crystalline factor A was from the
collection of the late W. Friedrich and presumably originated from
sewage sludge (P. Renz, personal communication). Cobinamide was
prepared by degradation of an aqueous solution of crystalline
cyanocobalamin (Hoffmann-LaRoche, Basel, Switzerland) with cerous
hydroxide by adaptation of the method described by Renz
(59). Separation of cobinamide and
-D-ribazole formed in this reaction was achieved by
preparative high-pressure liquid chromatography (HPLC) on an RP-18
column. XAD adsorbent resin (Serdolit AD-4; particle size, 0.1 to 0.2 mm; research grade [Serva, Heidelberg, Germany]) was used. Analytical HPLC was done on an ODS-Hypersil column (5 µm; 250 by 4.6 mm inner diameter, with Phenomenex Security Guard column protection containing two 4-mm C-18 cartridges). The pump used was a Gynkotek model M480G
with a vacuum on-line degasser, with a methanol-water (20:80 [vol/vol]) eluent and a flow rate of 1 ml/min. The injection volume was 20 µl, and the detector was a Gynkotek diode array detector UVD340 with detection at 355 nm. All chromatograms were obtained at
18°C, and data were processed by the Gynkotek HPLC data system Gynkosoft 5.50. All other chemicals were of the highest purity and were
purchased from Fluka (Neu-Ulm, Germany) Merck (Darmstadt, Germany), or
Aldrich (Steinheim, Germany).
Preparation of pseudovitamin B12 by guided biosynthesis. P. acidi-propionici was grown in a 100-liter fermentor which contained 1 kg of casein hydrolysate, 500 g of yeast extract, 170 g of NaH2PO4 · H2O, and 180 g of K3PO4 · H2O. The solution was sterilized at 120°C for 30 min. The medium was completed by adding autoclaved aqueous solutions of 750 g of glucose (1.5 liters), 60 g of MgCl2 · 6H2O, 860 mg of FeCl2 · 4H2O, and 1.7 g of CoCl2 · 6H2O (all 50 ml), as well as a sterile filtered solution of 400 mg of Ca-panthotenate, 30 mg of D-biotin, 1 g of cobinamide, and 10 g of adenine. The pH was adjusted to 6 to 7 by the addition of 400-ml batches of a solution containing 80 g of KHCO3 and 20 g of NaHCO3, and the temperature was kept at 37°C. The medium was inoculated with a 2-liter freshly grown culture of P. acidi-propionici. To prevent acidification of the batches during cell growth, the medium was further buffered with bicarbonate solution to keep the pH in the range of 6 to 7 and was supplied batchwise with aqueous glucose solution (250 g/500 ml). After 5 days of incubation, approximately 3 kg (wet weight) of cell material was harvested by centrifugation. The cells were resuspended in 5 liters of 0.1 M acetic acid (pH adjusted to 5.0 by NaOH) made 2 mM in cyanide by the addition of KCN and kept in closed half-filled, 1-liter bottles. The suspensions were incubated at 100°C for 20 min. A slightly red-colored cobamide-containing supernatant was obtained after centrifugation. The cell paste was reextracted once as described above. Portions of the pooled supernatants were run over a column of neutral aluminium oxide (3 by 10 cm) and loaded onto an XAD-4 column (3 by 10 cm; XAD grain diameter, 0.1 to 0.2 mm) to adsorb the cobamide. Prior to use, the XAD column was washed with 0.1 M KOH in methanol and then equilibrated with water. The cobamide-loaded column was rinsed with 10 bed volumes of water before eluting the cobamide with 80% methanol. The pooled methanol fractions were flash evaporated to dryness at 40°C. The residue was completely dissolved in approximately 20 ml of water. Further purification was performed by preparative HPLC (65) using an automated gradient controller and an RP-18 column (Nucleosil 120 C18; 1 by 25 cm [Marchery & Nagel]). Degassed methanol and 0.1% acetic acid were mixed as solvent components A and B and applied in two different systems at a flow rate of 3 ml/min. Solvent system I (23% A-77% B) led to the elution of pseudovitamin B12 after about 15 min; this was observed with a two-wavelength detector operating at 254 and 546 nm. Solvent system II (70% A-30% B, reached by a linear gradient within 10 min) was applied for approximately 30 min in order to elute the matrix. A linear program reversal reestablished the original conditions. The corrinoid-containing HPLC fractions were combined and flash evaporated to dryness. By crystallization from water-acetone, 230 mg (171 µmol) of pure pseudovitamin B12 (dried at 2 Pa, 6 h) was obtained. The sample of pseudovitamin B12 was subjected to UV-Vis, CD, mass, and NMR spectroscopic analysis as described below.
Isolation and purification of the corrinoids from C. cochlearium.
A culture of C. cochlearium was grown
anaerobically as reported elsewhere (49). Cells were
harvested aerobically and stored at
80°C. The isolation and
purification of the corrinoids from C. cochlearium in the
cyano form were carried out as described above for the isolation of
pseudovitamin B12. The amounts of solvents used in the
purification procedure were adapted to the amount of C. cochlearium cell material. From 50 g of frozen cells a sample of approximately 2 mg of crystalline corrinoids was obtained
(corresponding to 30 nmol of corrinoids/g [wet weight]). This sample
of corrinoids from C. cochlearium was subsequently analyzed
by HPLC and by UV-Vis, mass, and NMR spectroscopy. HPLC chromatograms
of the sample showed three fractions: I (retention time [RT] = 22.96 min, 63% relative integral area [RIA]), II (RT = 24.35 min,
22% RIA), and III (RT = 36.10 min, 15% RIA). All three
components had highly similar UV-Vis spectra (200 to 600 nm) which
showed no significant difference from those of pseudovitamin
B12 and of factor A. By peak matching, fraction I was
identified with pseudovitamin B12 and fraction III was
identified with factor A (see Fig. 3).
Spectroscopic data. UV-Vis and CD spectra were measured on Hitachi U-3000 and on Jasco-J715 instruments, respectively. Fast-atom-bombardment (FAB) MS spectra were recorded on a Finnigan MAT95 spectrometer (nitrobenzyl alcohol matrix, Cs+ bombardment). NMR spectra were obtained on a Varian 500 Unity Plus spectrometer equipped with field gradient facilities, a 5-mm indirect detection and 5-mm broadband direct detection probe (499.887 MHz, 1H; 125.15 MHz, 13C; and 50.66 MHz, 15N). NMR solutions had a sample size of 0.7 ml at 26°C. The solvents included 90% 10 mM phosphate buffer (pH 5.2) and 10% D2O. 1H, 13C, and 15N signal assignments were from 1H NMR spectra with water presaturation; 1H-broad-band-decoupled 13C NMR spectra; 1H,13C gradient-enhanced heteronuclear single-quantum coherence experiments (PFG-HSQC) (19, 38); 1H,15N gradient-enhanced heteronuclear single-quantum coherence experiments (PFG-HSQC) (19, 38), 2D gradient-enhanced heteronuclear multiple-bond coherence experiments (PFG-HMBC) (5, 38), 2D total correlation spectroscopy (watergate-TOCSY) (3, 14, 18, 56), and 2D rotating frame Overhauser enhancement spectroscopy (watergate-ROESY) (4, 11, 56). All 2D NMR experiments were parametrized as described earlier (42). The 2D gradient-enhanced HSQC-TOCSY (PFG-HSQC-TOCSY) experiment (8, 34) was parametrized as described elsewhere (68).
Pseudovitamin B12.
For UV-Vis analyses
(c = 6 · 10
4 M), with
max expressed in nanometers and where s
denotes the shoulders, the
max (log
) values were
276(4.26), 306(3.92), 321(3.89), 343s(4.11), 360(4.44), 410(3.53), 479s(3.67), 518(3.87), and 548(3.90). For CD
analyses (c = 6 · 10
4 M), where
the wavelengths of the extrema
max and
min and of the zero passages
0 are given
in nanometers, the molar decadic CD is indicated by 
, and
s denotes the shoulder the
max/
min(
) values were as follows:
578(1.48), 530s(
2.29), 488(
6.39), 429(14.13), 362(
11.21), 353(
7.97), 349(
8.38), 333(
4.77), 323(
6.82),
297(
0.35), 284s(
1.09), 269(
4.08), 258(
3.23),
247(
6.29), and 235(1.82). The
0 values were 559, 462, 381, 238, and 232. For FAB-MS analyses, the positive-ion spectra,
expressed as m/z (relative percent intensity) were
1,347.8(8), 1,346.8(29), 1,345.8(76), 1,344.8(100, MH+),
1,343.8(9), 1,342.8(10), 1,320.8(7), 1,319.8(15), 1,318.8(27, MH+-CN), 1,317.8(19),and 1,316.8(23). For NMR analyses
(c = 10 mM; see Fig. 4 for a 500-MHz 1H NMR
spectrum), a complete listing of assigned 1H,
13C, and 15N signals is given in Tables
1 and 2.
For the atom numbering of B12 derivatives, see Fig.
2.
|
|
|
Factor A.
For UV-Vis analyses (c = 6 · 10
4 M), the
max(log
s(4.07),
361(4.41), 408(3.50), 480s(3.62), 517(3.84), and 548(3.87).
For CD analyses (c = 6 · 10
4 M),
the
max/
min(
) values were
580(0.62), 541(
2.60), 533(
2.44), 492(
5.84), 430(13.18),
387s(0.38), 362(
11.66), 352s(
7.86), 334(
4.38), 324(
6.78), 313s(
4.58), 296(
1.39),
292(
1.43), 284(
0.58), 271(
2.39), 258(
0.96), 247(
3.98), and
235(3.50). The
0 values were 563, 461, 382, 241, and
230. For FAB-MS analyses, the m/z (relative percent
intensity) values were 1,361.5(8), 1,360.6(25), 1,359.6(77),
1,358.5(100.0, MH+), 1,357.5 (7), 1,333.6(13),
1,332.6(28, MH+-CN), 1,331.6(16), and 1,330.6(16).
For NMR analyses (c = 10 mM; see Fig. 4 for a 500-MHz
1H NMR spectrum), a complete listing of assigned
1H, 13C, and 15N signals is given
in Tables 1 and 2. For the atom numbering of B12
derivatives, see Fig. 2.
Sample of cyano corrinoids from C. cochlearium.
For
HPLC analyses, the three fractions were as follows: I, RT = 23 min
(65%); II, RT = 24.4 min (20%); III, RT = 36.1 min (15%).
For UV/Vis analyses, the
max values were 276, 305s, 321, 360, 410, 517, and 547. For CD analyses, the
values were 575, 429, 386s, and 236, the
min values were 542, 534, 492, 364, 351, 347, 333, 323, 311s, 296, 290, 284, 268, 261, and 248, and the
0 values were 563, 459, 384, 238, and 233. For
FAB-MS analyses, 1,361.8(8), 1,360.8(22), 1,359.8(50),
1,358.8(65.5), 1,357.8(13), 1,356.8(15), 1,347.8(9), 1,346.8(30),
1,345.8(70), 1,344.8(100), 1,343.8(11), 1,342.8(14), 1,333.8(10),
1,332.8(16), 1,331.8(15), 1,330.8(19), 1,320.8(6), 1,319.8(14),
1,318.8(23), 1,317.8(19), and 1,316.8(25). For NMR analyses
(c = 1.5 mM), see Fig. 4 for a 500-MHz 1H
NMR spectrum.
| |
RESULTS |
|---|
|
|
|---|
Guided biosynthesis of pseudovitamin B12. From about 3 kg of wet cells of a 100-liter P. acidi-propionici fermentation, supplemented with approximately 100 mg of adenine/liter of medium, 10 mg of cobinamide/liter, and 17 mg of CoCl2 · 6H2O/liter, a sample of about 230 mg (171 µmol, 20% yield relative to cobinamide) of bright-red crystalline pseudovitamin B12 was obtained and subjected to spectral analysis, as described below.
Spectroscopic analysis of pseudovitamin B12 and of
factor A.
Aqueous solutions of pseudovitamin B12 and
factor A exhibit practically identical UV-Vis and CD spectra. At
wavelengths of >300 nm they are similar to the spectrum of vitamin
B12 (29, 33). The UV-Vis spectra of both
purinylcobamides in aqueous solution display typical maxima at 548, 518, and 360 nm (
,
, and
bands) (33) and at 276 nm
(band of the coordinating nucleotide), as described earlier (see, for
example, reference 29). The spectra are consistent
with the structures of complete base-on corrinoids, with one cyanide
ligand bound to the cobalt center.

= 0.08 ppm) for Hre(C81); the largest
13C shift difference is observed (
= 1.2 ppm)
for CR3. An unambiguous assignment (pro-R or pro-S) of the signals of
all the magnetically nonequivalent methylene hydrogens of pseudovitamin
B12 and factor A could be derived from analysis of nuclear
Overhauser effects (NOEs) involving diastereotopic acetamide and
propionamide side chain methylene protons. The
1H,15N PFG-HSQC spectra of pseudovitamin
B12 in combination with watergate-ROESY spectra allowed the
assignment of all seven side chain amide nitrogens at natural isotopic
(15N) abundance, together with their directly bonded amide
protons (Table 2). With the exception of the d-side chain, for each
amide group the low-field proton signal was assigned to HE
due to the ROESY cross-peaks displayed between the amide protons and
side chain methylene protons, since only HE can be close in
space to the
-methylene protons of the carboxamide functions. Such
an inverse assignment concerning the d-side chain amide protons has already been reported, e.g., in NMR studies on methylcobalamin (68). This assignment is compatible with a specific
shielding effect of the nearby cobalt-coordinated nucleotide base
affecting both amide protons and causing highfield shifts of both amide signals. Analysis of the chemical shifts of the 1H,
15N, and 13C signals clearly confirmed the
constitution and base-on nature of pseudovitamin B12 and
factor A.
Notable chemical shift differences between the spectrum of vitamin
B12 on one hand and those of pseudovitamin B12
and factor A on the other hand could be observed for signals that were
assigned to the constitutionally different nucleotide bases. In the
spectra of pseudovitamin B12 and factor A, additional
1H upfield or downfield shifts with |
| > 0.1 ppm
with respect to the signals in the spectrum of vitamin B12
are only observed for protons that experience the different anisotropic
effects of the cobalt-coordinating nucleotide bases (Table 1): in the spectra of pseudovitamin B12 and factor A these are the
resonances of H(C3), Hre(C31), Hre(C171),
Hsi(C172), and H(CR1), and in the spectra of pseudovitamin
B12 these are the resonances also of H(C51), H(C7A), and
Hsi(C81). A comparison of the 13C NMR data for
pseudovitamin B12 and factor A with those for vitamin B12 also show similar chemical shifts (|
| < 2 ppm) of signals due to the constitutionally corresponding carbons, with
the exception of the signal for C1R in the spectrum of pseudovitamin
B12 and of the signals for C1R and C2R in the spectrum of
factor A. The observed NOE intensities were compatible with relevant
interproton distances from the crystal structures of vitamin
B12 and factor A (41, 42). For the spectra of
pseudovitamin B12 and factor A a strong NOE contact was
observed between H(C8N) and the methylene protons H(C131) and the
weaker ones of H(C8N) to the methyl groups H(C151) and H(C1A) as well
as to the methylene proton Hre(C172). Furthermore, in
the ROESY spectrum of pseudovitamin B12, weak contacts between H(C2N) and the methyl groups H(C51) and H(C7A), as
well as to the methylene protons Hsi(C31),
Hre(C31), and Hre(C81), exist. Likewise, the
spectrum of factor A exhibits the corresponding contacts of H(C21N) and
the methyl groups H(C51) and H(C7A), as well as the methylene protons
Hsi(C31), Hre(C31), and Hre(C81). All of these NOE contacts indicate the nucleotide base to be cobalt coordinating and suggest a "north-south" orientation with respect to the cobalt-corrin portion, constitutional, and conformational properties of pseudovitamin B12 and factor A in aqueous
solution, which are also indicated for vitamin B12 and
factor A by their crystal structures.
Analysis of the corrinoids isolated from C. cochlearium. The sample of crystalline cyano-corrinoids obtained from C. cochlearium was analyzed with respect to its composition by HPLC analysis and by UV-Vis, CD, mass, and NMR spectroscopy. These spectra could be examined by comparison with the spectra recorded for pseudovitamin B12 and factor A, two well-characterized, authentic reference compounds.
By a combination of careful HPLC and UV-Vis spectroscopic analysis, the sample was found to contain three corrinoid components, all having UV-Vis spectral features of Co
-cyano-7"-adeninylcobamides (29, 66). (Fig.
3). The most polar, major fraction
(RT = 23 min) and the least polar fraction (RT = 36.1 min)
had retention times and UV-Vis spectra identical to those of
pseudovitamin B12 and factor A, respectively. The fraction
of intermediate polarity (RT = 23.4 min) had similar UV-Vis
absorbance characteristics. The mass spectrum of the corrinoid sample
from C. cochlearium was consistent with the superposition of
the mass spectra of pseudovitamin B12 and factor A. The
spectrum of the sample from C. cochlearium exhibits a base
peak at m/z = 1,344.8 and the signal at
m/z = 1,358.8 with a relative intensity of 65%. These
signals are consistent with the pseudomolecular ions (MH+)
of pseudovitamin B12 and factor A (or an isomer, thereof),
respectively. In addition, signals at m/z = 1,318.8 and
m/z = 1,332.8, due to the corresponding fragment ions
(MH+-CN), have the same relative intensity ratio.
Comparison of the signal pattern in the FAB mass spectrum with the HPLC
trace suggests the sample from C. cochlearium to contain
pseudovitamin B12 (representing ca. 60%), factor A, and an
isomer of factor A (in total, ca. 40% of the sample).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Authentic samples of pseudovitamin B12
(29), prepared by guided biosynthesis as described here, and
of factor A were subjected to an extensive spectroscopic analysis. The
most detailed spectroscopic and structural information was obtained
from 1D and 2D homo- and heteronuclear NMR spectra in aqueous solution
(40). From experiments with B12 derivatives (in
aqueous medium with a mean deuterium content of 10% or less) signals
for nearly all 1H, 13C, and 15N
atoms were detected and could be assigned (a complete listing of
assigned 1H, 13C, and 15N signals
is given in Tables 1 and 2; see also Fig. 4 for 500 MHz 1H
NMR spectra of pseudovitamin B12 and factor A). The close
correspondence of the chemical shifts of most 1H,
15N, and 13C NMR signals in the spectra of the
purinylcobamides pseudovitamin B12 and factor A on the one
hand and of the DMB-cobamide vitamin B12 on the other
(16) supports a constitutionally and configurationally identical buildup of their cyano-Co(III)-corrin segments. The spectra
also indicate attachment at the ribose moiety of the purine base of the
cobalt coordinating nucleotide via its N7 in the unique
-configuration. Notable chemical shift differences can be observed only for signals that have been assigned either to the constitutionally different nucleotide bases or to protons that experience the different anisotropic effects of the cobalt-coordinating nucleotide bases. Detailed information on the conformational properties of pseudovitamin B12 and factor A in aqueous solution was obtained from the
ROESY data. By comparing the observed NOE intensities with the
interproton distances from the crystal structures of vitamin
B12 (45) and of factor A (41), the
base-on nature of pseudovitamin B12 and factor A in aqueous
solution and at pH 5.2 was confirmed, as was the north-south
orientation of the cobalt-coordinating purine bases in pseudovitamin
B12 and factor A.
The corrinoid sample from C. cochlearium thus represents a
cocrystallisate of pseudovitamin B12, factor A, and a third
cyanocobamide. The latter is indicated by the mass spectrum to have the
same molecular mass as factor A and is tentatively assigned the
structure of a
Co
-cyano-7"-[N6-methyl]adeninylcobamide,
a previously unknown purinylcobamide. In view of the earlier isolation
of pseudovitamin B12 and pseudocoenzyme B12
from C. tetanomorphum (2), the isolation of
purinylcobamides from the related C. cochlearium is not
unexpected. The corrinoids were isolated in their cyano-Co(III) forms,
which are unlikely to have a direct cofactor function (23,
43). The presence of purinylcobamides in C. cochlearium (and the absence of benzimidazolylcobamides, when
grown without the supplement of the corresponding base) can be
explained primarily by the difficulty (or even incapacity) of this
anaerobe to biosynthesize benzimidazoles. Such a situation is not
untypical of anaerobes (see, for example, references 39, 60, and 66). The appearance, besides
pseudovitamin B12, of its homologue factor A (and of
7"-[N6-methyl]adeninylcobamide), is in line
with frequent observations on the coexistence of purinylcobamides in
anaerobes (61). While the direct sources of the adeninyl
bases are not established, their origin from degradation of
oligo(deoxy)nucleotides has been suggested tentatively (28,
61). The appearance of
7"-[N6-methyl]adeninylcobamides would lend
further support to this suggestion, since derivatives of
N6-methyladenine are ubiquitous natural products
of oligonucleotides (50). Clearly, additional methyl groups
increase the hydrophobicity of the nucleotide appendage. A related
situation is encountered with the naturally occurring
benzimidazolylcobamides, which may also differ by the degree of their
biosynthetic methylation at the nucleoside base (60).
The determination of two of the cobamides in C. cochlearium
as the 7"-purinylcobamides pseudovitamin B12 and factor A
points to the functional relevance in this anaerobe of the
corresponding coenzyme forms, pseudocoenzyme B12
(Co
-5'-deoxy-5'-adenosyl-7"-adeninylcobamide) and
adenosyl factor A
(Co
-5'-deoxy-5'-adenosyl-7"-[2-methyl]adeninylcobamide). These two adenosylcobamides are known to exist in their base-off constitution mainly in neutral aqueous solution, in contrast to coenzyme B12 (47; W. Fieber, B. Hoffmann, H. Bothe, W. Buckel, R. Konrat, and B. Kräutler,
unpublished data). It is also likely that the corresponding
methyl-Co(III)-corrinoids (Co
-methyl-7"- adeninylcobamide and
Co
-methyl-7"-[2-methyl]adeninylcobamide) have a
functional role in biosynthetic methyl group transfer reactions (e.g.,
in some methanogens, such as in a variety of Methanococcales spp. [66]).
The different constitution of the nucleotide bases of coenzyme B12 and of the purinylcobamides could be considered to be of functional relevance in view of the recently established base-off-His-on mode of binding of the corrinoid cofactor to some adenosyl-dependent mutases (55, 58) (see above). The predominance of the base-off form of the purinylcobamides might therefore be considered to be a means in support of a proper preorganization of these "complete" corrinoids and to assist their incorporation in the base-off-His-on mode into the apo form of glutamate mutase. To test this notion, preliminary comparisons were carried out with the adenosylcobamides coenzyme B12, pseudocoenzymec B12, and adenosyl factor A as cofactors of glutamate mutase from C. cochlearium. In contrast to the simple expectations, Michaelis-Menten studies of glutamate mutase revealed coenzyme B12 to bind better than its base-off analogues pseudocoenzyme B12 and adenosyl factor A and the catalytic activity of the mutase to be similar, irrespective of the adenosyl-corrinoid cofactor used (Fieber et al., unpublished). Accordingly, a direct catalytic advantage for the adenosylcobamide-dependent glutamate mutase from C. cochlearium by the use of the purinylcobamides pseudocoenzyme B12 and adenosyl-factor A instead of the benzimidazolycobamide coenzyme B12 can be excluded.
The purinylcobamides carry a nucleotide base that is able to undergo H bonding with H donors and acceptors and that can become protonated (47), even when coordinated to the corrin-bound cobalt center. This situation is drastically different from that in the benzimidazolylcobamides, where H bonding and protonation of the nucleotide base cannot directly occur in the cobalt-coordinated state. A mechanism for the control of the organometallic reactivity of protein-bound corrinoid cofactors involves weakening of the cobalt coordination of the axial transligand, conveyed (in part) by H bonding it to other protein residues in "regulatory" diads or triads (21, 43, 51, 52). Only in their base-off-His-on form can bound benzimidazolylcobamides be set to participate directly in such H-bonded regulatory units via a coordinated histidine. A possible functional advantage of the presence of a purinyl base in complete corrinoid cofactors in their H-bonding base-on constitution may therefore not be dismissed. Indeed, diol-dehydratase and cobamide-dependent ribonucleotide reductase are two enzymes that depend upon adenosylcobamides and which have been discovered lately to carry their corrinoid cofactors in the base-on form (1, 48, 63).
While two of the native corrinoids of the obligate anaerobes C. tetanomorphum and C. cochlearium are widely occurring purinylcobamides, C. tetanomorphum has been shown to produce benzimidazolylcobamides when supplied with benzimidazoles (70), and coenzyme B12 can act as functional corrinoid cofactor of glutamate mutase in both of these clostridia (9, 37, 60). The incapacity of C. tetanomorphum and C. cochlearium to biosynthesize benzimidazoles parallels the situation encountered in several other anaerobes (29, 39, 66). The native cobamides from C. cochlearium are indicative of the biosynthesis of three relevant adeninylcobamides by this anaerobe. Two of these homologous corrinoids (pseudovitamin B12 and factor A) are known from other anaerobes also (61). It will be of interest to definitively clarify the structure of the third cobamide of C. cochlearium and to examine its occurrence in other anaerobic microorganisms.
| |
ACKNOWLEDGMENTS |
|---|
We thank Wolfgang Fieber and Wolfgang Schmidt for communicating their results on organometallic B12 derivatives and Iris Schall for her technical assistance. We are grateful to K. H. Ongania for measuring FAB mass spectra. We thank Paul Renz for providing us with authentic factor A and Hoffmann-LaRoche for a generous gift of vitamin B12.
This study was supported by the European Commission (TMR project FMRX.CT96.0018), by the Austrian National Science Foundation (FWF, projects P-13595 and P-12639), by the German Science Foundation (Deutsche Forschungsgemeinschaft), and by the Fonds der Chemischen Industrie.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institut fur Organische Chemie, Universitat Innsbruck, Innrain 52a, A-6020 Innsbruck, Austria. Phone: 43-512-507-5200. Fax: 43-512-507-2892. E-mail: bernhard.kraeutler{at}uibk.ac.at.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Abend, A., R. Nitsche, V. Banderian, E. Stupperich, and J. Rétey. 1998. Dioldehydratase binds coenzyme B12 in the "base-on" mode: ESR investigations on cob(II)alamin. Angew. Chem. Int. Ed. Engl. 37:625-627[CrossRef]. |
| 2. |
Barker, H. A.,
H. Weissbach, and R. D. Smith.
1958.
A coenzyme containing pseudovitamin B12.
Proc. Natl. Acad. Sci. USA
44:1093-1097 |
| 3. | Bax, A., and D. G. Davies. 1985. Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Reson. 63:207-213. |
| 4. | Bax, A., and D. G. Davies. 1985. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65:355-360. |
| 5. | Bax, A., and M. F. Summers. 1986. 1H and 13C assignments from sensitivity-enhanced detection of heteronuclear multiple-bond connectivity by 2D multiple quantum NMR. J. Am. Chem. Soc. 108:2093-2094[CrossRef]. |
| 6. | Beatrix, B., O. Zelder, F. Kroll, G. Örlygsson, B. T. Golding, and W. Buckel. 1995. Evidence for a mechanism involving transient fragmentation in coenzyme-B12-dependent carbon skeleton rearrangements. Angew. Chem. Int. Ed. Engl. 34:2398-2401[CrossRef]. |
| 7. | Bigger, G. W., J. M. Elliot, and T. R. Rickard. 1976. Estimated ruminal production of pseudovitamin B12, factor A and factor B in sheep. J. Anim. Sci. 43:1077-1081. |
| 8. | Bodenhausen, G., and D. Ruben. 1980. Natural abundance nitrogen-15 NMR by enhanced spectroscopy. Chem. Phys. Lett. 69:185-189[CrossRef]. |
| 9. | Bothe, H., G. Bröker, U. Müller, I. Schall, S. Textor, B. T. Golding, and W. Buckel. 1998. Mechanisms of coenzyme B12-dependent carbon-carbon and carbon-oxygen rearrangements, p. 253-264. In B. Kräutler, B. T. Golding, and D. Arigoni (ed.), Vitamin B12 and B12-proteins. Verlag Wiley-VCH, Weinheim, Germany. |
| 10. | Bothe, H., D. J. Darley, S. P. Albracht, G. J. Gerfen, B. T. Golding, and W. Buckel. 1998. Identification of the 4-glutamyl radical as an intermediate in the carbon skeleton rearrangement catalyzed by coenzyme B12-dependent glutamate mutase from Clostridium cochlearium. Biochemistry 37:4105-4113[CrossRef][Medline]. |
| 11. | Bothner-By, A. A., R. L. Stephens, J. Lee, C. D. Warren, and R. W. Jeanloz. 1984. Structure determination of a tetrasaccharide: transient nuclear Overhauser effects in the rotating frame. J. Am. Chem. Soc. 106:811-813[CrossRef]. |
| 12. | Brandt, L. J., L. H. Bernstein, and A. Wagle. 1977. Production of vitamin B12 analogues in patients with small-bowel overgrowth. Ann. Intern. Med. 87:546-551. |
| 13. |
Brandt, L. J.,
L. Goldberg,
L. H. Bernstein, and G. Greenberg.
1979.
The effect of bacterially produced vitamin B12 analogues (cobamides) on the in vitro absorption of cyanocobalamin.
Am. J. Clin. Nutr.
32:1832-1836 |
| 14. | Braunschweiler, L., and R. R. Ernst. 1983. Coherence transfer by isotropic mixing: application to proton correlation spectroscopy. J. Magn. Reson. 53:521-528. |
| 15. | Buckel, W., and B. T. Golding. 1996. Glutamate and 2-methyleneglutarate mutase: from microbial curiosities to paradigms for coenzyme B12-dependent enzymes. Chem. Rev. Soc. 25:329-337. |
| 16. | Calafat, A. M., and L. G. Marzilli. 1993. Investigation of B12 derivatives with inorganic ligands using 2D NMR spectroscopy. J. Am. Chem. Soc. 115:9182-9190[CrossRef]. |
| 17. | Chen, H. P., and E. N. G. Marsh. 1997. How enzymes control the reactivity of adenosylcobalamin: effect on coenzyme binding and catalysis of mutations in the conserved histidine-aspartate pair of glutamate mutase. Biochemistry 36:7884-788932[CrossRef][Medline]. |
| 18. | Davis, D. G., and A. Bax. 1985. Assignment of complex 1H NMR spectra via 2D-homonuclear Hartmann-Hahn spectroscopy. J. Am. Chem. Soc. 107:2820-2821[CrossRef]. |
| 19. | Davis, A. L., J. Keeler, E. D. Laue, and D. Moskau. 1992. Experiments for recording pure-absorption heteronuclear correlation spectra using pulsed field gradients. J. Magn. Reson. 98:207-216. |
| 20. | Dion, H. W., D. G. Calkins, and J. J. Pfiffner. 1952. Hydrolysis products of pseudovitamin B12. J. Am. Chem. Soc. 74:1108. |
| 21. |
Drennan, C. L.,
S. Huang,
J. T. Drummond,
R. G. Matthews, and M. L. Ludwig.
1994.
How a protein binds B12: a 3.0 Å X-ray structure of B12-binding domains of methionine synthase.
Science
266:1669-1674 |
| 22. | Eberhard, G., H. Schlayer, H. Joseph, E. Fridrich, B. Utz, and O. Müller. 1988. Untersuchungen zur biologischen Funktion der Nukleotidbase von Vitamin B12. Biol. Chem. Hoppe-Seyler 369:1091-1098[Medline]. |
| 23. | Ellenbogen, L., and B. A. Cooper. 1991. Vitamin B12, p. 491-536. In L. Lawrence, and J. Machlin (ed.), Handbook of vitamins. Marcel Dekker, Inc., New York, N.Y. |
| 24. | Eschenmoser, A. 1988. Vitamin B12: Experimente zur Frage nach dem Ursprung seiner molekularen Struktur. Angew. Chem. Int. Ed. Engl. 27:5-40[CrossRef]. |
| 25. | Ford, J. E., and J. W. G. Porter. 1952. Some properties of vitamin B12-like factors from calf faeces. 1. Characteristics of different fractions. Biochem. J. 51:v-vi. |
| 26. | Ford, J. E., E. S. Holdsworth, S. K. Kon, and J. W. G. Porter. 1953. Occurrence of the various vitamin B12 active compounds. Nature 171:150[CrossRef][Medline]. |
| 27. | Ford, J. E., E. S. Holdsworth, and S. K. Kon. 1955. The biosynthesis of vitamin B12-like compounds. Biochem. J. 59:86-93[Medline]. |
| 28. | Friedmann, H. C., and L. M. Cagen. 1970. Microbial biosynthesis of B12-like compounds. Annu. Rev. Microbiol. 24:159-208[CrossRef][Medline]. |
| 29. | Friedrich, W. 1975. Vitamin B12 und verwandte Corrinoide, p. 173. In R. Ammon, and W. Dirscherl (ed.), Fermente, Hormone, und Vitamine, vol. III/2. Georg Thieme Verlag, Stuttgart, Germany. |
| 30. |
Friedrich, W., and K. Bernhauer.
1956.
Beiträge zur Chemie und Biochemie der "Cobalamine." II. Mitteilung: Über den Abbau der "Cobalamine" mit CerIII-hydroxid. 7 -[D-Ribofuranosido]-adenin, ein Abbauprodukt des Pseudovitamin B12.
Chem. Ber.
89:2507-2512.
|
| 31. | Friedrich, W., and K. Bernhauer. 1957. Über den Abbau des Faktors A mit CerIII-hydroxyd. Chem. Ber. 90:465-470. |
| 32. | Friedrich, W., H. Dellweg, G. Gross, E. Becher, S. Spaude, and K. Bernhauer. 1957. Vitamin B12-ähnliche Faktoren des Faulschlamms, p. 62-72. In H. C. Heinrich (ed.), Vitamin B12 and intrinsic factor. Enke, Stuttgart, Germany. |
| 33. | Giannotti, C. 1982. Electronic spectra of B12 and related systems, p. 393. In D. Dolphin (ed.), B12, vol. 1. John Wiley & Sons, New York, N.Y. |
| 34. | Gronenborn, A. M., A. Bax, P. T. Wingfield, and G. M. Clore. 1989. A powerful method of sequential proton resonance assignment in proteins using relayed 15N-1H multiple quantum coherence spectroscopy. FEBS Lett. 243:93-98[CrossRef][Medline]. |
| 35. | Hoffmann, B., R. Konrat, H. Bothe, W. Buckel, and B. Kräutler. 1999. Structure and dynamics of the B12-binding subunit of glutamate mutase from Clostridium cochlearium. Eur. J. Biochem 263:178-188[Medline]. |
| 36. |
Hollenstein, R., and E. Stupperich.
1993.
Assignment of 15N-NMR resonances of vitamin B12 analogues by 2D-[15N,1H]long range correlation: fully [15N]-labelled co- -cyano-5-hydroxybenzimidazolylcobamide (factor III) and derivatives.
Helv. Chim. Acta
76:1258-1265[CrossRef].
|
| 37. |
Holloway, D. E., and E. N. G. Marsh.
1994.
Adenosylcobalamin-dependent glutamate mutase from Clostridium tetanomorphum: over-expression in E. coli, purification and characterization of the recombinant enzyme.
J. Biol. Chem.
269:20425-20430 |
| 38. | Hurd, R. E., and B. K. John. 1991. Gradient-enhanced proton-detected heteronuclear multiple-quantum coherence spectroscopy. J. Magn. Reson. 91:648-653. |
| 39. | Keck, B., and P. Renz. 2000. Salmonella typhimurium forms adenylcobamide and 2-methyladenylcobamide, but no detectable cobalamin during strictly anaerobic growth. Arch. Microbiol. 173:76-77[CrossRef][Medline]. |
| 40. | Konrat, R., M. Tollinger, and B. Kräutler. 1998. New NMR structural and dynamical probes of organometallic B12 derivatives, p. 349-368. In B. Kräutler, B. T. Golding, and D. Arigoni (ed.), Vitamin B12 and B12-proteins. Verlag Wiley-VCH, Weinheim, Germany. |
| 41. | Kopf, J., K. von Deuten, R. Bieganowski, and W. Friedrich. 1981. X-ray crystal structure analysis of factor A (2-methyladeninyl-cyanocobamide), a native vitamin B12-analogue. Z. Naturforsch. 36c:506-515. |
| 42. | Kratky, C., G. Färber, K. Gruber, K. Wilson, Z. Dauter, H.-F. Nolting, R. Konrat, and B. Kräutler. 1995. Accurate structural data demystify B12: high-resolution solid-state structure of aquocobalamin perchlorate and structure analysis of the aquocobalamin ion in solution. J. Am. Chem. Soc. 117:4654-4670[CrossRef]. |
| 43. | Kräutler, B. 1998. B12-coenzymes, the central theme, p. 3-43. In B. Kräutler, B. T. Golding, and D. Arigoni (ed.), Vitamin B12 and B12-proteins. Verlag Wiley-VCH, Weinheim, Germany. |
| 44. | Kräutler, B. 1998. B12-nomenclature and a suggested atom-numbering, p. 517-522. In B. Kräutler, B. T. Golding, and D. Arigoni (ed.), Vitamin B12 and B12-proteins. Verlag Wiley-VCH, Weinheim, Germany. |
| 45. |
Kräutler, B.,
R. Konrat,
E. Stupperich,
G. Färber,
K. Gruber, and C. Kratky.
1994.
Direct evidence for the conformational deformation of the corrin ring by the nucleotide base in vitamin B12: synthesis and solution spectroscopic and crystal structure of Co -cyanoimidazolylcobamide.
Inorganic Chem.
33:4128-4139[CrossRef].
|
| 46. | Kräutler, B., and C. Kratky. 1996. Vitamin B12: the haze clears. Angew. Chem. 108:179-181; Angew. Chem. Int. Ed. Engl. 35:168-170. |
| 47. |
Ladd, J. N.,
H. P. C. Hogenkamp, and H. A. Barker.
1961.
Structure of cobamide coenzymes: influence of pH on absorption spectra and ionophoretic mobilities.
J. Biol. Chem.
236:2114-2118 |
| 48. |
Lawrence, C. C.,
G. J. Gerfen,
V. Samano,
R. Nitsche,
M. J. Robins,
J. Rétey, and J.-A. Stubbe.
1999.
Binding of cob(II)alamin to the adenosylcobalamin-dependent ribonucleotide reductase from Lactobacillus leichmanii.
J. Biol. Chem.
274:7039-7042 |
| 49. | Leutbecher, U., R. Böcher, D. Linder, and W. Buckel. 1992. Glutamate mutase from Clostridium cochlearium. Purification, cobamide content and stereospecific inhibitors. Eur. J. Biochem. 205:759-765[Medline]. |
| 50. |
Limbach, P. A.,
P. F. Crain, and J. A. McCloskey.
1994.
The modified nucleosides of RNA.
Nucleic Acids Res.
22:2183-2196 |
| 51. | Ludwig, M. L., and R. G. Matthews. 1997. Structure-based perspectives on B12-dependent enzymes. Annu. Rev. Biochem. 66:269-313[CrossRef][Medline]. |
| 52. | Mancia, F., N. H. Keep, A. Nakagawa, P. F. Leadlay, S. McSweeney, B. Rasmussen, P. Bösecke, O. Diat, and P. R. Evans. 1996. How coenzyme B12 radicals are generated: the crystal structure of methylmalonyl-coenzyme A mutase at 2 Å resolution. Structure 4:339-350[Medline]. |
| 53. | Marsh, E. N. G., and D. E. Holloway. 1992. Cloning and sequencing of glutamate mutase component S from Clostridium tetanomorphum. FEBS Lett. 310:167-170[CrossRef][Medline]. |
| 54. | Marsh, E. N. G., and D. P. Ballou. 1998. Coupling of cobalt-carbon bond homolysis and hydrogen atom abstraction in adenosylcobalamin-dependent glutamate mutase. Biochemistry 37:11864-11872[CrossRef][Medline]. |
| 55. | Marsh, E. N. G., D. E. Holloway, and H. P. Chen. 1998. Glutamate mutase, p. 253-264. In B. Kräutler, B. T. Golding, and D. Arigoni (ed.), Vitamin B12 and B12-proteins. Verlag Wiley-VCH, Weinheim, Germany. |
| 56. | Piotto, M., V. Sautek, and V. Sklenar. 1992. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solution. J. Biomol. NMR 2:661-665[CrossRef][Medline]. |
| 57. |
Ragsdale, S. W.,
P. A. Lindahl, and E. Münck.
1987.
Mössbauer, EPR and optical studies of the corrinoid/iron-sulfur protein involved in the synthesis of acetyl coenzyme A by Clostridium thermoaceticum.
J. Biol. Chem.
262:14289-14297 |
| 58. | Reitzer, R., K. Gruber, G. Jogl, U. G. Wagner, H. Bothe, W. Buckel, and C. Kratky. 1999. Glutamate mutase from Clostridium cochlearium: the structure of a coenzyme B12-dependent enzyme provides new mechanistic insights. Structure 7:891-902[Medline]. |
| 59. | Renz, P. 1972. Some intermediates in the biosynthesis of vitamin B12. Methods Enzymol. 18:85. |
| 60. | Renz, P. 1998. Investigations of the biosynthesis of the 5,6-dimethylbenzimidazole moiety of vitamin B12, p. 119-130. In B. Kräutler, B. T. Golding, and D. Arigoni (ed.), Vitamin B12 and B12-proteins. Verlag Wiley-VCH, Weinheim, Germany. |
| 61. | Renz, P. 1999. Biosynthesis of the 5,6-dimethylbenzimidazole moiety of cobalamins and of other bases found in natural corrinoids, p. 557-575. In R. Banerjee (ed.), Chemistry and Biochemistry of B12. John Wiley & Sons, New York, N.Y. |
| 62. |
Rickes, E. L.,
N. G. Brink,
F. R. Koniuszy,
T. R. Wood, and K. Folkers.
1948.
Crystalline vitamin B12.
Science
107:396-397 |
| 63. | Shibata, N., J. Masuda, T. Tobimatsu, T. Toraya, K. Suto, Y. Morimoto, and N. Yasuoka. 1999. A new mode of B12 binding and the direct participation of a potassium ion in enzyme catalysis: X-ray structure of diol dehydratase. Structure 7:997-1008[Medline]. |
| 64. | Smith, E. L., and L. F. J. Parker. 1948. Purification of anti-pernicious anaemia factor. Biochem. J. 43:VIII. |
| 65. | Stupperich, E., I. Steiner, and M. Rühlemann. 1986. Isolation and analysis of bacterial cobamides by high-performance liquid chromatography. Anal. Biochem. 155:365-370[CrossRef][Medline]. |
| 66. | Stupperich, E., and B. Kräutler. 1988. Pseudovitamin B12 or 5-hydroxybenzimidazolyl-cobamide are the corrinoids found in methanogenic bacteria. Arch. Microbiol. 149:268-271[CrossRef]. |
| 67. | Stupperich, E., H.-J. Eisinger, and S. Schurr. 1990. Corrinoids in anaerobic bacteria. FEMS Microbiol. Rev. 87:355-360[CrossRef]. |
| 68. | Tollinger, M., T. Dérer, R. Konrat, and B. Kräutler. 1997. An efficient method for the preparation of methylcobalamin, nature's organometallic methyl transfer catalyst. J. Mol. Catal. A 116:147-155[CrossRef]. |
| 69. | Tollinger, M., R. Konrat, B. H. Hilbert, E. N. G. Marsh, and B. Kräutler. 1998. How a protein prepares for B12 binding: structure and dynamics of the B12-binding subunit of glutamate mutase from Clostridium tetanomorphum. Structure 6:1021-1033[Medline]. |
| 70. |
Weissbach, H.,
J. Toohey, and H. A. Barker.
1959.
Isolation and properties of B12-coenzymes containing benzimidazole or dimethyl-benzimidazole.
Proc. Natl. Acad. Sci. USA
45:521-525 |
| 71. | Zelder, O., B. Beatrix, U. Leutbecher, and W. Buckel. 1994. Characterization of the coenzyme-B12-dependent glutamate mutase from Clostridium cochlearium produced in Escherichia coli. Eur. J. Biochem. 226:577-585[Medline]. |
| 72. | Zelder, O., B. Beatrix, F. Kroll, and W. Buckel. 1995. Coordination of a histidine residue of the protein component S to the cobalt/Atom in coenzyme B12-dependent glutamate mutase from Clostridium cochlearium. FEBS Lett. 369:252-254[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»